« FDA Obtains Permanent Injunction Against Scientific Laboratories, Inc. The U.S. | Main | FDA Approvals - Korean FDA Approves The CereTom(R) Portable CT Scanner (Medical News »

FDA Announces Limited Return of Heartworm Drug to U.S. Market


FDA Announces Limited Return of Heartworm Drug to U.S. Market
ProHeart 6 Sustained Release Injectable for Dogs, manufactured by Fort Dodge Animal Health, is an approved injectable sustained-release heartworm prevention product for dogs. FDA is concurring with its limited return, to the U.S. veterinary market under a risk minimization and restricted distribution program designed to manage the re-introduction of ProHeart 6 to provide for safe, appropriate use of the product while minimizing risk to dogs.
 

©2006 FDA-News.com. All rights reserved.